GILD vs NSP · P/E 18, rev $7.80B vs P/E 35, rev $3.58B
Gilead Sciences Inc (GILD) versus Insperity Inc (NSP) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Insperity Inc (NSP) is a staffing & employment services company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported NSP revenue for 2026-06-30 was $3.58B. Net income was $37.0M. Revenue was up 89.0% from 2026-03-31 to 2026-06-30. NSP currently screens at market cap $2.20B and trailing P/E 34.6.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. NSP currently screens at market cap $2.20B and trailing P/E 34.6.
Not investment advice. Open the GILD and NSP stock pages for the full models.
Not investment advice.